S Basi, JB Lewis - American Journal of Kidney Diseases, 2006 - Elsevier ALBUMINURIA HAS been known to be a predictor of poor renal outcomes for patients
with diabetes mellitus for many years. 1 , 2 and 3 It also was shown that
albuminuria is a risk factor for cardiovascular and kidney disease in ... Cited by 56 - Related articles - All 6 versions
- ►diabetesjournals.org WY So, APS Kong, RCW Ma, R Ozaki, CC … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—After a median follow-up period of 39.4 months (interquartile range
20.3–55), all-cause mortality rate increased from 1.2% (95% CI 0.8–1.7) to
18.3% (9.1–27.5) (P for trend <0.001) as renal function deteriorated from ... Cited by 40 - Related articles - BL Direct - All 7 versions
D De Zeeuw, D Ramjit, Z Zhang, AB Ribeiro, … - Kidney international, 2006 - nature.com Type 2 diabetes is becoming the leading cause of end-stage renal disease (ESRD)
worldwide. Prevalence of ESRD and the antihypertensive response to
renin–angiotensin system intervention are suggested to vary among ... Cited by 21 - Related articles - BL Direct - All 6 versions
A Kamijo-Ikemori, T Sugaya, K Kimura - Clinica Chimica Acta, 2006 - Elsevier Liver type fatty acid binding protein (L-FABP) of 14.4 kDa is expressed in human
proximal tubules. In order to evaluate the clinical significance of urinary
L-FABP as a biomarker in renal disease, a monoclonal antibody against human ... Cited by 16 - Related articles - All 3 versions
- ►pubget.com [PDF] XL Yang, WY So, APS Kong, P Clarke, CS … - Diabetologia, 2006 - Springer Page 1. ARTICLE End-stage renal disease risk equations for Hong Kong Chinese
patients with type 2 diabetes: Hong Kong Diabetes Registry ... Cited by 15 - Related articles - BL Direct - All 5 versions
PCY Tong, APS Kong, WY So, MHL Ng, X … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 3,983 patients who underwent assessment
for diabetes complications were recruited. Subjects were categorized into five
groups. Group I included subjects with hematocrit below the normal ... Cited by 13 - Related articles - BL Direct - All 6 versions
H Makino, M Haneda, T Babazono, T Moriya, … - The Journal of International Medical Research, 2005 - ingentaconnect.com We planned the INNOVATION study to determine whether telmisartan, an
angiotensin-2-receptor blocker, delays the progression of renal disease from
incipient nephropathy to overt nephropathy in hypertensive or normotensive ... Cited by 12 - Related articles - BL Direct - All 5 versions
WY So, XL Yang, RC Ma - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 11 - Related articles - BL Direct - All 2 versions
N Perico, P Ruggenenti, G Remuzzi - Expert Review of Cardiovascular Therapy, 2004 - ingentaconnect.com Diabetic nephropathy has become the single most important cause of end-stage
renal disease in the USA, Europe and Japan. The earliest marker of incipient
diabetic nephropathy is the transition of normoalbuminuria to ... Cited by 10 - Related articles - All 4 versions
E Imai, S Ito, M Haneda, JCN Chan, H Makino - Hypertension Research, 2006 - nature.com Diabetic nephropathy (DN) is a leading cause of endstage renal disease (ESRD) in
Japan and Hong Kong. Asian patients are known to be more predisposed to DN and
ESRD than Caucasians. Strict blood glucose and blood pressure control are ... Cited by 11 - Related articles - BL Direct - All 4 versions
